Fund moves

McKesson Corporation (MCK): TCW Group Inc added to its stake +11K shares

TCW Group Inc added to its stake in McKesson Corporation, per its Q1 2025 13F.

155K
Shares reported · +11K vs prior quarter
0.93%
Disclosed portfolio weight
$104M
Reported value
Holdings as of
Mar 31, 2025
Filed
May 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 3, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  2. Mar 4, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  3. Mar 24, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  4. Apr 9, 2025CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
  5. Apr 23, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  6. Apr 24, 2025FDARecall: SEKISUI DIAGNOSTICS LLC SERUM HCG OSOMGENZME CONTROL SET.
  7. Apr 24, 2025FDARecall: ABBOTT POINT OF CARE TEST CREA I-STAT (25/BX) ABBTPT CARTRIDGE.
  8. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC ANTI-B BIOCLONE 10ML3X10ML.
  9. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS BUN (60/CR 5CR/PK) ORCLNL REAGENT.
  10. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCH AUSAB ANTI-HBS (100/EA) REAGENT.
  11. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT PROGESTERONE (100TESTS) REAGENT.
  12. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARCHITECT FREE T4ABBDIA CALIBRATOR.
  13. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC ANTI-TPO ASSAY 100TST B REAGENT.
  14. Apr 24, 2025FDARecall: ABBOTT RAPID DX N AMERICA LLC, TEST CHOLESTEC LDXLIPID PROFILE (10/BX 50BX/CS) CASSETTES.
  15. Apr 24, 2025FDARecall: HEMOCUE INC GLUC AQUEOUS 1HI/LO HEMCUE CONTROL KIT.
  16. Apr 24, 2025FDARecall: ORTHO CLINICAL DIAGNOSTICS INC VITROS CALCIUM (L-SEQUESTER) (300/PK) REAGENT.
  17. Apr 24, 2025FDARecall: ABBOTT DIAGNOSTICS ARC CARBON DIOXIDE6X5ML B CALIBRATOR.
  18. Apr 25, 2025FDARecall: Infuvite Adult, multiple vitamins injection, Baxter, Five of Vial 1 (5 mL) and Five of Vial 2 (5mL), Rx Only, Sterile, Manufactured for: Sandoz Inc., Princeton…
  19. Apr 25, 2025FDARecall: Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC…
  20. Apr 29, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000

What came next

  1. May 12, 2025CongressDisclosed sale of MCK — reported range $15,001 - $50,000
  2. May 19, 2025InsiderOfficer sold ~$394K of MCK shares in the open market
  3. May 22, 2025Insider · 2 peopleInsiders: 2 sales (~$5.4M)
  4. May 23, 2025Insider · 3 peopleInsiders: 3 sales (~$684K)
  5. May 27, 2025InsiderOfficer sold ~$704K of MCK shares in the open market
  6. May 28, 2025Insider · 4 peopleInsiders: 4 sales (~$2.0M)
  7. May 30, 2025InsiderOfficer sold ~$2.06M of MCK shares in the open market
  8. Jun 6, 2025InsiderCEO sold ~$13.7M of MCK shares in the open market
  9. Jul 11, 2025InsiderCEO sold ~$13.7M of MCK shares in the open market
  10. Jul 11, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  11. Jul 30, 2025FDARecall: Clearview Strep A Exact II Dipstick Respiratory Kit, CLIA Waived. Catalog Number: 4581225020
  12. Aug 8, 2025InsiderOfficer sold ~$218K of MCK shares in the open market
  13. Aug 15, 2025InsiderCEO sold ~$8.09M of MCK shares in the open market
  14. Aug 22, 2025InsiderCEO sold ~$8.42M of MCK shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

How this filing works

Explore the data

Common questions

What does this filing report about McKesson Corporation (MCK) stock?

TCW Group Inc added to its stake in McKesson Corporation, per its Q1 2025 13F. Now 155K shares, $104M reported value, 0.93% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: May 7, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about McKesson Corporation recently?

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MCK page.

Does this mean MCK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at McKesson Corporation

Everything OQRO holds on this company is on its MCK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data